» Articles » PMID: 33290195

Impact of Guidelines on Hypertension Control in the Elderly

Overview
Journal Curr Pharm Des
Date 2020 Dec 8
PMID 33290195
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypertension control is a crucial measure to reduce cardiovascular (CV) risk, and blood pressure (BP) treatment targets have been recently revised to address this issue. However, achieving the recommended goal may be challenging.

Objective: We aimed to assess the prevalence of uncontrolled hypertension, according to the US hypertension guidelines, among elderly participants in an Italian nationwide epidemiological survey, the relevant clinical correlates, and the agreement with the application of the European guidelines.

Methods: Elderly (≥65y) volunteers enrolled in an Italian nationwide survey underwent BP measurement using standard protocols. Uncontrolled hypertension was defined as BP≥130/80 mmHg. Agreement of this definition with those from European guidelines (≥140/90 mmHg; ≥140/80 mmHg) was tested using Cohen's kappa. Selfreported information on modifiable/non-modifiable CV risk factors was also collected.

Results: Of the 13,162 treated hypertensive elderly, 69.8% had uncontrolled hypertension. They tended to be overweight/obese men with diabetes. Overall agreement between US and European guidelines was poor to good (κ = 0.289, p<0.001 and κ = 0.691, p<0.001 based on the 140/90 and 140/80 mmHg threshold, respectively). Elderly participants with controlled hypertension were more likely to report a history of CV or chronic kidney disease. No difference in lifestyle habits was observed by BP control status.

Conclusion: Real-world data identify limited concordance between guidelines in terms of BP target achievement among older hypertensive Italians and highlights the need to spread awareness of the CV risk, especially in the presence of diabetes and obesity.

Citing Articles

TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice.

Filipiak K, Camafort Babkowski M, Cameli M, Carugo S, Ferri C, Irisov D Cardiol J. 2022; 29(5):730-738.

PMID: 36117294 PMC: 9550320. DOI: 10.5603/CJ.a2022.0087.

References
1.
Piepoli M, Hoes A, Agewall S, Albus C, Brotons C, Catapano A . 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by.... Atherosclerosis. 2016; 252:207-274. DOI: 10.1016/j.atherosclerosis.2016.05.037. View

2.
Manson J, Cook N, Lee I, Christen W, Bassuk S, Mora S . Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. N Engl J Med. 2018; 380(1):23-32. PMC: 6392053. DOI: 10.1056/NEJMoa1811403. View

3.
Saydah S, Fradkin J, Cowie C . Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004; 291(3):335-42. DOI: 10.1001/jama.291.3.335. View

4.
Armstrong R . When to use the Bonferroni correction. Ophthalmic Physiol Opt. 2014; 34(5):502-8. DOI: 10.1111/opo.12131. View

5.
Del Pinto R, Ferri C . Hypertension Management at Older Age: An Update. High Blood Press Cardiovasc Prev. 2018; 26(1):27-36. DOI: 10.1007/s40292-018-0290-z. View